Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 90, Issue 5, 1996, Pages 568-571

  Rieckmann, Karl H ^a,b   Yeo, Anthony E T ^a   Edstein, Michael D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

Author keywords

Chemotherapy; Malaria; Plasmodium falciparum; PS 15; WR99210

Indexed keywords

4,6 DIAMINO 1,2 DIHYDRO 2,2 DIMETHYL 1 [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] 1,3,5 TRIAZINE; ANTIMALARIAL AGENT; FOLIC ACID ANTAGONIST; N [3 (2,4,5 TRICHLOROPHENOXY)PROPOXY] N' ISOPROPYLIMIDOCARBONIMIDIC DIAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIMALARIAL ACTIVITY; ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALARIA; MONKEY; MULTIDRUG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM;

ANIMALIA; PLASMODIUM FALCIPARUM; SAIMIRI SCIUREUS;

EID: 0029858680     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(96)90326-0     Document Type: Article

References (12)

1. Canfield, C. J. (1986). New antimalarials under development. In: Chemotherapy of Malaria, 2nd edition, Bruce-Chwatt, L. J. (editor). Geneva: World Health Organization, Monograph Series no. 27, pp. 99-100.
2. Canfield, C. J., Milhous, W. K., Ager, A. L., Rossan, R. N., Sweeney, T. R., Lewis, N. J. & Jacobus, D. P. (1993). PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists. American Journal of Tropical Medicine and Hygiene, 49, 121-126.
3. Childs, G. E. & Lambros, C. (1986). Analogues of N-benzyloxy-dihydrotriazine: in vitro antimalarial activity against Plasmodium falciparum. Annals of Tropical Medicine and Parasitology, 80, 177-181.
4. Edstein, M. D., Corcoran, K. D., Shanks, G. D., Ngampochjana, M., Hansukjariya, P., Sattabongkot, J. & Webster, H. K. (1994). Evaluation of WR250417 (a proguanil analogue) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model. American Journal of Tropical Medicine and Hygiene, 50, 181-186.
5. Kotecka, B. M. & Rieckmann, K. H. (1995). In vivo-in vitro model to assess chloroquine activity in monkeys. Chemotherapy, 41, 134-140.
6. Lambros, C. & Vanderberg, J. P. (1979). Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology, 65, 418-420.
7. Rieckmann, K. H. (1973). The in vitro activity of experimental antimalarial compounds against strains of Plasmodium falciparum with varying degrees of sensitivity to pyrimethamine and chloroquine. In: Chemotherapy of Malaria and Resistance to Antimalarials. Geneva: World Health Organization, Technical Report Series no. 529, p. 58.
8. Rieckmann, K. H., Sax, L. S., Campbell, G. H. & Mrema, J. E. (1978). Drug sensitivity of Plasmodium falciparum. An in vitro microtechnique. Lancet, i, 22-23.
9. Taylor, R. B., Moody, R. R. & Ochekpe, N. A. (1987). Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high performance liquid chromatography. Journal of Chromatography, 416, 394-399.
10. Thaithong, S. & Beale, G. H. (1981). Resistance often Thai isolates of Plasmodium falciparum to chloroquine and pyrimethamine by in vitro tests. Transactions of the Royal Society of Tropical Medicine and Hygiene, 75, 271-273.
11. Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 193, 673-675.
12. Yeo, A. E. T. & Rieckmann, K. H. (1994). The activity of PS-15 in combination with sulfamethoxazole. Tropical Medicine and Parasitology, 45, 136-137.